.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Portable slit-lamp cataract imaging is rapidly becoming a vital tool for ophthalmology screenings in remote or resource-limited settings. Recently, researchers conducted a prospective validation study to compare the Mobile Imaging Device for Anterior Segment (MIDAS) and the I.C.P. portable slit-lamp against a standard slit-lamp built-in camera (ASC). This comparison utilized the Lens Opacities Classification System III (LOCS III) to evaluate the accuracy of nuclear opalescence and color grading.
The study involved 66 patients, resulting in 198 digital images. Consequently, three independent graders, including an ophthalmologist and a family medicine resident, analyzed the output. This diverse grading team highlights the potential for these devices to be used across different levels of healthcare delivery. Furthermore, the researchers calculated the intraclass correlation (ICC) to determine how consistently the devices performed across different observers.
The results revealed that all three devices achieved excellent ICC scores for assessing Nuclear Colour (NC). For instance, the MIDAS recorded an ICC of 0.837, while the standard ASC reached 0.892. However, the reliability for Nuclear Opalescence (NO) was notably lower. Both portable devices showed only fair ICC for NO, whereas the standard ASC system surprisingly recorded a poor ICC in this category. Additionally, graders expressed the highest subjective confidence when viewing images from the standard ASC system.
Subjective image quality assessments also favored the conventional equipment. Specifically, 96.5% of graders preferred ASC images, compared to roughly 74% for MIDAS. Nevertheless, portable slit-lamp cataract imaging remains a functional alternative for large-scale screenings where high-end stationary equipment is unavailable. Therefore, clinicians should consider these devices as useful screening adjuncts rather than complete replacements for traditional slit-lamp examinations.
Portable devices like MIDAS provide excellent reliability for grading nuclear color. However, they are currently less consistent for nuclear opalescence grading compared to standard built-in cameras. They are highly effective for screening and documentation in remote areas.
Standard cameras usually offer higher resolution and superior lighting control. Consequently, this leads to higher grader confidence and better subjective image quality, which are crucial for detailed diagnostic assessments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study compares MIDAS and portable slit-lamps with standard devices for cataract grading, highlighting their utility in remote ophthalmology screenings....
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
